Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2026-01-13 @ 11:17 PM
Study NCT ID:
NCT03146468
Status:
UNKNOWN
Last Update Posted:
2021-09-23
First Post:
2017-05-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation
Sponsor:
Melbourne Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-05-07
First Submit QC Date:
None
Study First Post Date:
2017-05-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-21
Last Update Post Date:
2021-09-23
Last Update Post Date Type:
ACTUAL